5-Aminosalicylic acid (mesalazine) use in Crohnʼs disease: A survey of the opinions and practice of Australian gastroenterologists-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

5-Aminosalicylic acid (mesalazine) use in Crohnʼs disease: A survey of the opinions and practice of Australian gastroenterologists

Published:2007-08 Issue:8 Volume:13 Page:1009-1015
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Gearry Richard B.,Ajlouni Yousef,Nandurkar Sanjay,Iser John H.,Gibson Peter R.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference30 articles.

1. Systematic review: the use of mesalazine in inflammatory bowel disease

2. The Case Against Using 5-Aminosalicyclates in Crohnʼs Disease

3. Debate: Should Mesalamine Be Used in Crohnʼs Disease?

4. The Case for Using 5-Aminosalicyclates in Crohnʼs Disease

5. European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term disease course, cost and prognosis of inflammatory bowel disease: epidemiological studies of a European and a Danish inception cohort;APMIS;2023-06

2. 5-Aminosalicylic Acid Prevents Disease Behavior Progression and Intestinal Resection in Colonic and Ileocolonic Crohn’s Disease Patients: A Retrospective Study;Canadian Journal of Gastroenterology and Hepatology;2021-08-09

3. The use of 5‐aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study;United European Gastroenterology Journal;2020-10

4. Trends of 5-Aminosalicylate Medication Use in Patients With Crohn Disease;Inflammatory Bowel Diseases;2020-05-29

5. Stopping Mesalamine Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes;Clinical Gastroenterology and Hepatology;2020-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3